Kintor Pharmaceutical Limited
KNTPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $503 | $524 | $3,221 | $25 |
| - Cash | $147 | $445 | $1 | $1 |
| + Debt | $133 | $254 | $286 | $160 |
| Enterprise Value | $489 | $333 | $3,506 | $184 |
| Revenue | $5 | $0 | $0 | $34 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$5 | -$42 | -$3 | $34 |
| % Margin | -94.6% | – | – | 100% |
| EBITDA | -$128 | -$1,056 | -$956 | -$828 |
| % Margin | -2,567.4% | – | – | -2,418.8% |
| Net Income | -$155 | -$1,061 | -$954 | -$842 |
| % Margin | -3,105.8% | – | – | -2,460% |
| EPS Diluted | -0.36 | -2.47 | -2.53 | -2.36 |
| % Growth | 85.4% | 2.4% | -7.2% | – |
| Operating Cash Flow | -$199 | -$388 | -$1 | -$1 |
| Capital Expenditures | -$2 | -$3 | -$0 | -$0 |
| Free Cash Flow | -$201 | -$390 | -$1 | -$1 |